Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Identifying risk factors for COPD and adult-onset asthma: an umbrella review

Judith C.S. Holtjer, Lizan D. Bloemsma, Rosanne J.H.C.G. Beijers, Merel E.B. Cornelissen, Bart Hilvering, Laura Houweling, Roel C.H. Vermeulen, George S. Downward, Anke-Hilse Maitland-Van der Zee on behalf of the P4O2 consortium
European Respiratory Review 2023 32: 230009; DOI: 10.1183/16000617.0009-2023
Judith C.S. Holtjer
1Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lizan D. Bloemsma
2Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands
4Amsterdam Public Health, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosanne J.H.C.G. Beijers
5Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rosanne J.H.C.G. Beijers
Merel E.B. Cornelissen
2Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands
4Amsterdam Public Health, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart Hilvering
2Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Houweling
1Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands
2Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roel C.H. Vermeulen
1Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands
6Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George S. Downward
1Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands
6Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anke-Hilse Maitland-Van der Zee
2Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands
4Amsterdam Public Health, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.h.maitland@amsterdamumc.nl
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background COPD and adult-onset asthma (AOA) are the most common noncommunicable respiratory diseases. To improve early identification and prevention, an overview of risk factors is needed. We therefore aimed to systematically summarise the nongenetic (exposome) risk factors for AOA and COPD. Additionally, we aimed to compare the risk factors for COPD and AOA.

Methods In this umbrella review, we searched PubMed for articles from inception until 1 February 2023 and screened the references of relevant articles. We included systematic reviews and meta-analyses of observational epidemiological studies in humans that assessed a minimum of one lifestyle or environmental risk factor for AOA or COPD.

Results In total, 75 reviews were included, of which 45 focused on risk factors for COPD, 28 on AOA and two examined both. For asthma, 43 different risk factors were identified while 45 were identified for COPD. For AOA, smoking, a high body mass index (BMI), wood dust exposure and residential chemical exposures, such as formaldehyde exposure or exposure to volatile organic compounds, were amongst the risk factors found. For COPD, smoking, ambient air pollution including nitrogen dioxide, a low BMI, indoor biomass burning, childhood asthma, occupational dust exposure and diet were amongst the risk factors found.

Conclusions Many different factors for COPD and asthma have been found, highlighting the differences and similarities. The results of this systematic review can be used to target and identify people at high risk for COPD or AOA.

Abstract

This umbrella review provided an overview of nongenetic risk factors for both COPD and adult-onset asthma. Commonly found factors included smoking, BMI, air pollution, early life exposures and occupational exposures. https://bit.ly/3kyeWZL

Background

COPD is one of the most common chronic respiratory disorders, with a prevalence ranging from 3.6 to 10.1% [1, 2] Currently, COPD is the third leading cause of death worldwide [3], with 2–6% of global disability-adjusted life years attributed to COPD in 2015 [4]. Additionally, COPD patients are at an increased risk of developing extrapulmonary manifestations or comorbidities that highly affect disease burden, such as cardiovascular diseases and lung cancer [5, 6, 7]. Besides COPD, another 300 million children and adults globally are estimated to be suffering from asthma [8]. Even though adult-onset asthma (AOA) is less studied than childhood asthma, previous research shows that incidence has been rising over the past two decades [9]. For example, de Marco et al. [10] showed asthma prevalence in Italy to have increased by 38% between 1991 and 2010, irrespective of age. Distinguishing between COPD and asthma can be difficult, especially in older adults, as the predicted forced expiratory volume in 1 s falls to 50% in both asthma and COPD patients over 60 years old [11]. Some patients with asthma develop COPD later in life and some patients with COPD show clinical features commonly observed in asthma [12]. For patients who show characteristics of both COPD and asthma, the label asthma–COPD overlap syndrome (ACOS) is being considered [13]. It has been widely reported that patients suffering from ACOS have worse disease outcomes, such as more exacerbations and a more rapid decline in lung function, than patients suffering from only asthma or COPD [13, 14, 15]. As there is considerable overlap between the two conditions, this could mean overlapping risk factors as well.

As both COPD and AOA have a high disease burden, and there is no curative treatment for COPD [16], early identification and prevention are key. To optimise prevention strategies, a better understanding of especially nongenetic risk factors for developing either condition is needed. Additionally, risk factors for childhood asthma are well established, but it is unclear how those risk factors translate to AOA. Furthermore, previous research has shown similarities in nongenetic risk factors for developing either COPD or AOA, such as smoking and high exposure to air pollution [17]. However, to our knowledge, there is currently no overview comparing risk factors for COPD and asthma. The aim of this systematic umbrella review is to provide an overview and comparison of all nongenetic risk factors for COPD and AOA, identifying similarities as well as differences.

Methods

Search strategy

We conducted an umbrella review, a systematic collection and assessment of multiple systematic reviews and meta-analyses [18]. The review was conducted according to the study protocol, registered in the International Prospective Register of Systematic Reviews (PROSPERO-CRD42021284614) and according to PRISMA guidelines. The full PRISMA checklist can be found in the supplemental material.

PubMed was systematically searched from inception to 1 February 2023 to identify systematic reviews and meta-analyses of studies examining one or multiple nongenetic risk factors for either COPD or AOA. The search strategy consisted of terms on COPD, asthma, epidemiology, aetiology, risk factors and study design (full search strategy in the supplemental material). In addition, reference lists of included papers were screened for additional relevant reviews that might have been missed during the initial search. A first screening was independently done by two researchers (J.C.S.H. and L.D.B.) based on title and abstract. Subsequently, the full text of all relevant articles was assessed for eligibility by one researcher (J.C.S.H.), with an additional researcher (M.E.B.C.) assessing a random 10% of the articles. Initial discrepancies were first discussed amongst the reviewers with a third reviewer (R.J.H.C.G.B.) being available for final decision making in case of disagreement. However, this did not occur.

Inclusion and exclusion criteria

Systematic reviews with or without meta-analyses of observational epidemiological studies, including systematic reviews of Mendelian randomisation studies, in humans that assessed nongenetic risk factors for incidence asthma or COPD were included. Regarding AOA, reviews were included regardless of specifying age of onset. Only studies available in English were included. Studies examining risk factors for either mortality, exacerbations or management of either disease were excluded. Additionally, studies examining the impact of another disease on development of either COPD or AOA were considered noneligible. When multiple analyses or reviews included the same original studies, the most recent one was included.

Data extraction

Data extraction was performed by one reviewer (J.C.S.H.), with a second reviewer (M.E.B.C.) extracting data from a random 10% for quality control purposes. From each eligible article, the authors, year of publication, examined nongenetic risk factor(s), examined outcome, number of epidemiological studies included, the total number of participants per review and the main conclusions were recorded. Additionally, for AOA it was recorded whether age of onset was specified. Study quality and risk of bias of the included reviews was checked by applying the Joanna Briggs Institute (JBI) checklist for systematic reviews and research synthesis [19]. Scores were given for every included aspect, resulting in a score ranging from 1 (poorly conducted) to 11 (well conducted). For studies without a meta-analysis, the maximum score is 10.

Results

Literature review

Our literature search identified 2040 publications. Of those, 1867 were excluded following title and abstract review (figure 1), mainly because they focused on genetic risk factors or on exacerbations or management of disease. Additionally, one review was identified through snowballing. Of those, 99 were excluded after reviewing the full texts, resulting in 75 eligible articles included in this umbrella review. Of these, 45 focused on risk factors for COPD, 28 on asthma and two reviews included both COPD and asthma. Out of the 75 included reviews, 45 included a meta-analysis and narrative review, 12 conducted only a meta-analysis but no narrative review and 18 only included a narrative review.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Results of the searches, screening and data extraction.

Regarding AOA, 47 of the included studies mentioned COPD, addressing 45 different risk factors. A selection of characteristics of the included articles are described in tables 1 and 2 for AOA and COPD, respectively. Full characteristics are shown in tables S1 and S2. A summary of the found risk factors and their corresponding effect sizes is shown in tables 3 and 4, respectively. For both AOA and COPD, the JBI scores ranged between 5 and 11. For AOA, age of onset was not clear for all papers, with only seven specifying AOA. An additional four compared exposed versus nonexposed individuals within occupational settings, implying adult-onset. All were included, but this uncertainty was noted. When a meta-analysis was conducted, the meta-results are given as opposed to single-study results.

View this table:
  • View inline
  • View popup
TABLE 1

Characteristics of 30 included systematic reviews for adult-onset asthma, ranked by Joanna Briggs Institute (JBI) score

View this table:
  • View inline
  • View popup
TABLE 2

Characteristics of 47 included systematic reviews for COPD, ranked by Joanna Briggs Institute (JBI) score

View this table:
  • View inline
  • View popup
TABLE 3

Overview of the identified risk factors for adult-onset asthma, and their corresponding effect sizes

View this table:
  • View inline
  • View popup
TABLE 4

Overview of the identified risk factors for COPD and their corresponding effect sizes

Asthma

Air pollution and chemical exposures

Eight reviews identified either chemical exposures or air pollution as risk factors for asthma [21, 27, 31, 38, 43, 46, 47, 49]. Sio and Chew [31] identified exposure to several types of air pollution, including nitrogen dioxide (NO2), particulate matter and ozone as risk factors for AOA, with included pooled odds ratios (ORs) ranging between 1.03 and 1.22. Yu et al. [21] reported that high indoor residential formaldehyde exposure (>22.5 µg·m−3) was associated with an increased risk of asthma as compared to low exposure (≤22.5 µg·m−3), with a meta OR (mOR) of 1.81 (95% CI 1.18–2.78). Moreover, Nurmatov et al. [27] reported that domestic exposure to volatile organic compounds (VOCs), i.e. aromatic VOCs, chlorinated hydrocarbons, propylene glycol and glycol ethers, alkanes, alcohols, aldehydes, ketones, and terpenes, increased asthma risk. Doust et al. [46] reported both occupational and nonoccupational pesticide exposure to increase asthma risk. However, there was variation in pooled estimates for pesticide exposure, ranging from 0.41 (95% CI 0.15–1.11) to 3.67 (95% CI 1.19–11.30) for exposed versus nonexposed, with inconsistent reporting on the type of pesticide examined. Jaakkola and Knight [47] found a high exposure to phthalates, such as heated polyvinyl chloride fumes, increased asthma risk, with an mOR of 1.55 (95% CI 1.18–2.05). Canova et al. [43] found that domestic paint use was associated with asthma, with one study providing an OR of 1.60 (95% CI 1.00–2.50). The final two reviews did not find either consistent or significant results. Vincent et al. [49] did not find significant associations between exposure to cleaning products and an increased risk of asthma. The review by Kakutani et al. [38] did not show arachidonic acid intake to be consistently associated with asthma.

Early life exposures

Four reviews identified early life factors as risk factors for asthma later in life [26, 29, 41, 45]. First, a review by Flaherman and Rutherford [45] identified that both a high weight during middle childhood (body mass index (BMI) ≥85th percentile for age and gender) (mOR 1.32, 95% CI 0.82–2.40) and high birth weight (≥3.8 kg) (mOR 1.26, 95% CI 0.88–1.82) could increase the risk of asthma. Jaakkola et al. [41] identified pre-term delivery as a possible risk factor, with ORs of included studies ranging between 1.86 (95% CI 0.23–12.00) and 1.14 (95% CI 0.92–1.40). However, these results were not statistically significant. Mu et al. [29] reported low birth weight to be a risk factor, with a birth weight of <2500 g to be associated with a higher risk of asthma (mOR 1.25, 95% CI 1.12–1.40) as compared to babies with a birth weight between 2500 and 4000 g. Lastly, Shen et al. [26] studied early life vitamin D deficiency and risk of asthma later in life, but found no statistically significant association (mOR 0.57, 95% CI 0.35–0.93).

Nutrition and weight status

Four reviews focused on nutritional or weight-related risk factors [23, 31, 40, 42]. Beuther and Sutherland [40] found that compared to a healthy BMI, overweight and obese participants had mORs of 1.38 (95% CI 1.17–1.62) and 1.92 (95% CI 1.43–2.59) for developing asthma, respectively. This is in accordance with Sio and Chew [31], who found an mOR of 2.02 (95% CI 1.63–2.50) for participants with a BMI of ≥30 kg·m−2. Additionally, Mikkelsen et al. [42] found a meta risk ratio (mRR) of 1.05 (95% CI 1.03–1.07) per kg·m−2 increase in BMI. Chen et al. [23] identified lower zinc and selenium plasma levels as possible risk factors for asthma, with a standardised mean difference (SMD) between asthma patients and healthy controls of −0.26 (95% CI −0.40–−0.13) for zinc and −0.06 (95% CI −0.13–0.02) for selenium. However, they did not provide which unit they standardised to.

Occupational exposures

Six reviews examined occupational risk factors for asthma [20, 25, 30, 34, 44, 48]. Romero Starke et al. [20] focused on healthcare workers exposed to cleaning products with an mRR of 1.67 (95% CI 1.11–2.50) among nurses exposed to different types of cleaning products compared to unexposed nurses. Folletti et al. [48] also reported cleaning workers to be at an increased risk, with ORs of the included studies ranging between 1.50 and 3.00. Baur et al. [44] reported exposure to workplace irritants, such as chloride, led to an increased asthma risk. Wiggans et al. [34] reported wood dust exposure in wood workers to increase asthma risk, with only one study providing a risk ratio of 1.53 (95% CI 1.25–1.87) as compared to the general population. Furthermore, Zhang et al. [25] identified exposure to organic dust when compared to healthy individuals to increase asthma risk in different occupations. They found associations with paper/wood dust (mOR 1.62, 95% CI 1.38–1.90), flour/grain (mOR 1.48, 95% CI 1.11–1.97) and textile dust (mOR 1.50, 95% CI 1.08–2.09). Lastly, Macan et al. [30] found that exposure to persulphates, such as hair bleach, was associated with asthma in hairdressers.

Physiological, personal and socioeconomic characteristics

Of the included reviews, 11 studied either physiological, personal, or socioeconomic risk factors [22, 24, 28, 31–33, 35–37, 39, 42]. Wang et al. [22] examined exposure to greenness as a risk factor for asthma, but found contradicting results, with one of their included studies finding an increased asthma risk, one finding exposure to greenness to be a protective factor and one not showing an association. Etminan et al. [24] found acetaminophen use was associated with an increased risk of asthma when compared to nonexposed individuals (mOR 1.63, 95% CI 1.46–1.77). Four studies focused on aspects of the home environment [28, 31, 32, 39]. The first, by Rodriguez et al. [32], compared participants living in urban environments to participants in rural environments and found people living in urban areas to have an increased asthma risk (mOR 1.89, 95% CI 1.47–2.41). The second, by Sharpe et al. [28], reported that exposure to indoor fungi from the Penicillium, Aspergillus and Cladosporium species, could increase asthma risk when compared to individuals with lower exposure. However, an OR was only given for one of the included studies (1.25, 95% CI 0.99–1.58). The third, by Takkouche et al. [39], examined having furry pets indoors as a risk factor for asthma and found an mOR for exposure to any pet of 1.58 (95% CI 0.99–2.54). The fourth, by Sio and Chew [31], found household factors such as mould to be associated with asthma, with ORs of the included studies ranging between 1.43 and 1.73. Cong et al. [33] investigated the effect of ambient temperature drops on asthma risk, per 1°C decrease, but found no significant results (mOR 1.00, 95% CI 0.93–1.08). Furthermore, Uphoff et al. [35] found a lower socioeconomic status (SES) to be associated with increased asthma risk (mOR 1.38, 95% CI 1.37–1.39). Tan et al. [36] reported that participants with late-onset asthma were more likely to be female (58–75%) and smokers (56%), while Sio and Chew [31] found males to be at an increased risk (mOR 1.30, 95% CI 1.23–1.38). Both Mikkelsen et al. [42] and Sio and Chew [31] examined smoking as a risk factor, with the former finding it a protective factor (risk ratio 0.97, 95% CI 0.96–0.99) and the latter finding an association with an increased asthma risk (mOR 1.66, 95% CI 1.44–1.90). However, Mikkelsen et al. [42] only included two papers on smoking, with the other included paper finding smoking to be associated with an increased asthma risk. Additionally, Sio and Chew [31] found an association with second-hand smoke exposure (mOR 1.44, 95% CI 1.30–1.60) [31]. Mikkelsen et al. [42] found early as compared to average age at puberty to be a risk factor (mRR 1.37, 95% CI 1.15–1.64), where late versus average age at puberty was found to be a protective factor (mRR 0.93, 95% CI 0.90–0.96) [42]. Lastly, Lieberoth et al. [37] found a younger age at menarche to be associated with asthma risk (mOR 1.37, 95% CI 1.15–1.64).

COPD

Air pollution and chemical exposures

We identified 19 reviews, studying six different risk factors [46, 54, 57, 60, 61, 64, 69, 70, 72, 76, 77, 79, 81–83, 85, 86, 93, 94]. Park et al. [60] found an association between exposure to ambient fine particulate matter (PM2.5) and COPD (meta hazard ratio (mHR) 1.18, 95% CI 1.13–1.23) per 10 μg·m-3 increase, which was also found by Chen et al. [72] (mOR 1.73, 95% CI 1.16–2.58). Additionally, they found significant associations between NO2 and COPD, which was also found by Zhang et al. [82], with a 10 μg·m-3 increase in NO2 being associated with an mHR of 1.07 (95% CI 1.00–1.16) [60] and an mRR of 1.02, respectively. Indoor air pollution caused by indoor biomass burning was found to be a risk factor for COPD in several reviews [54, 57, 61, 69, 70, 72, 76, 77, 79, 81, 83, 85, 86, 93, 94]. Found mORs ranged between 1.52 (95% CI 1.39–1.67), found by Njoku et al. [61] and 3.16 (95% CI 1.82–5.49), found by Kamal et al. [69], when compared to unexposed controls. Doust et al. [46] identified both occupational and nonoccupational pesticide exposure as a possible risk factor, with ORs of the included studies ranging from 1.05 (95% CI 0.74–1.51) to 4.10 (95% CI 2.20–6.30) for exposed versus nonexposed individuals, with inconsistent reporting on the type of pesticide examined. Yang et al. [57] reported living in polluted areas, defined as areas with high levels of outdoor air pollution, as a risk factor for COPD, with an mOR of 1.63 (95% CI 1.20–2.21). Lastly, Ryu et al. [64] reported being exposed to vapours, gases, dusts and fumes to increase COPD risk (mOR 1.43, 95% CI 1.19–1.73).

Early life exposures

12 reviews identified risk factors in early life [50, 52, 57, 68, 70, 72, 80, 85, 92, 93, 94]. Six of these focused on respiratory problems in early life and COPD risk [50, 57, 72, 85, 93, 94], with found mORs ranging between 2.23 (95% CI 1.63–3.07) [50] and 3.44 (95% CI 1.33–8.90) [72]. Additionally, Duan et al. [50] identified childhood asthma (mOR 3.45, 95% CI 2.37–5.02), maternal smoking during both pregnancy and childhood (mOR 1.42, 95% CI 1.17–1.72), child maltreatment, e.g. physical abuse (mOR 1.30, 95% CI 1.18–1.42), and low birth weight (mOR 1.58, 95% CI 1.08–2.32) as risk factors for COPD. They did not find statistical significant associations for childhood environmental tobacco smoke exposure (mOR 1.30, 95% CI 0.83–1.61), which is in accordance with results found by Lee et al. [92] (mRR 0.88, 95% CI 0.72–1.07), or premature birth (mOR 1.17, 95% CI 0.87–1.58) [50]. Childhood asthma was found to be a risk factor by Sutradhar et al. [70], Ali [80] and Asamoah-Boaheng et al. [52], with, respectively, an OR of 6.90 (95% CI 4.90–9.50), an mOR of 3.00 (95% CI 2.25–4.00) and an mOR of 7.87 (95% CI 5.40–11.45). Lastly, Ma et al. [68] found childhood wheeze to increase the risk of COPD later in life (mRR 5.31, 95% CI 1.03–27.27).

Nutrition and weight status

10 reviews identified nutritional factors or weight-related aspects as risk factors for COPD [51, 57, 63, 72–74, 76, 78, 79, 85], of which five studies identified having a low BMI as a risk factor for COPD [57, 72, 74, 76, 85]. The found mORs ranged from 1.96 (95% CI 1.78–2.17), found by Zhang et al. [74], to 3.83 (95% CI 2.22–6.60), found by Yang et al. [57]. Additionally, Zhang et al. [74] found an association between COPD and overweight (mOR 0.80, 95% CI 0.73–0.87) and obese (mOR 0.86, 95% CI 0.73–1.02) participants, but found it to be a protective factor, which was also found by Adeloye et al. [85] (mOR 0.90, 95% CI 0.80–0.90). Chen et al. [72] found an mOR of 0.96 (95% CI 0.76–1.22) for participants with a BMI >28 kg·m−2.

Both van Iersel et al. [73] and Zheng et al. [63] identified a Western-style diet, characterised by a high intake of refined grains, red and processed meat, saturated fats, sweets, and desserts, as a risk factor for COPD, with the latter providing an mOR of 2.12 (95% CI 1.64–2.74) [63]. Parvizian et al. [51] studied unhealthy dietary patterns, i.e. Western diets and diets high in carbohydrates, but the results were not statistically significant (mOR 1.22, 95% CI 0.84–1.76). Additionally, they found a healthy dietary pattern, i.e. high in fruit and vegetables, to reduce COPD risk (mOR 0.88, 95% CI 0.82–0.94)) [51]. Bellou et al. [79] found vitamin D deficiency to be a risk factor for COPD (mOR 1.77, 95% CI 1.18–2.64). Chen et al. [72] identified drinking history as a risk factor and found an mOR of 0.82 (95% CI 0.54–1.23). Drinking history was not further defined. Lastly, both van Iersel et al. [73] and Salari-Moghaddam et al. [78] identified high consumption of red and processed meat as a risk factor for COPD, with the latter finding an mHR of 1.08 (95% CI 1.03–1.13) for every 50 g increase per week in intake.

Occupational exposures

11 reviews identified occupational exposures associated with an increased risk of COPD [44, 56–58, 66, 67, 71, 79, 84, 88, 93]. Eight of those studies found that workers exposed to dust as compared to nonexposed had an increased risk of COPD [56–58, 66, 71, 79, 84, 93], with found mORs ranging from 0.97 (95% CI 0.68–1.39) by Bellou et al. [79] to 1.79 (95% CI 1.15–2.79), found by Yang et al. [57]. Both Guillien et al. [67] and Fontana et al. [88] found an association between COPD and agricultural work, with only the former providing an mOR of 1.77 (95% CI 1.50–2.08) [67]. Lastly, Baur et al. [44] found an association between workplace irritants, such as chloride or welding fumes, and COPD.

Physiological, personal and socioeconomic characteristics

Physiological, personal and socioeconomic risk factors for COPD were examined by 20 reviews [53–55, 57, 59, 61, 62, 65, 70, 72, 75, 76, 79, 85–87, 89–91, 93]. 12 reviews identified active smoking as the main risk factor for COPD [54, 55, 57, 61, 70, 72, 79, 85–87, 89, 90] and six identified second-hand smoking to be a risk factor [72, 79, 85, 92–94]. Regarding active smoking, found mORs ranged from 2.89 (95% CI 2.63–3.17), found by Forey et al. [90], to 5.50 (95% CI 4.20–7.20), found by Sutradhar et al. [70]. Regarding second-hand smoke exposure, found risk estimates range from an mRR of 1.20 (95% CI 1.08–1.34) found by Lee et al. [92], to an mOR of 1.56 (95% CI 1.40–1.74) [79]. Sutradhar et al. [70] found women who chewed tobacco to be at an increased risk for COPD (OR 12.90, 95% CI 3.40–49.40) [70]. Bellou et al. [79] identified waterpipe smoking as a risk factor (mOR 3.18, 95% CI 1.25–8.09).

Five studies identified having a low SES as a risk factor [57, 62, 76, 85, 93], with an mOR of 1.61 (95% CI 1.21–2.15) found by Yang et al. [57], using an education level of ≤9 years as a proxy for low SES, and ORs ranging from 0.80 (95% CI 0.50–1.30) to 3.70 (95% CI 1.90–7.00) in included studies in the review by Gershon et al. [62], using measures such as education, occupation and income as proxies for SES.

Additionally, four reviews identified older age as a risk factor [54, 70, 75, 85]. The first, by Sutradhar et al. [70], found that compared to 40–49-year-old participants, participants aged 50–59 and 60–69 years have an OR of 2.20 (95% CI 1.60–3.00) and 4.70 (95% CI 3.50–6.40), respectively. The second, by Gan et al. [75] found that with age, female smokers have a greater incline in lung function. The third, by Adeloye et al. [85] found that under the age of 50 years, COPD risk increased with an mOR of 1.50 (1.30–1.50) per 10-year increase, as well as an increased risk in participants aged 50–59 (mOR 2.10, 95% CI 1.80–2.60) and older than 60 (mOR 4.2, 95% CI 3.10–5.60).

Two reviews identified biomarkers as risk factors [53, 91]. Chaudhary et al. [91] found an association between elevated serum homocysteine and COPD risk (mean difference 3.05) as compared to healthy controls, with elevated serum homocysteine being associated with cigarette smoking. Su et al. [53] found several inflammatory markers to be associated with COPD risk. Elevated C-reactive protein compared to regular levels had an SMD of 1.21 (95% CI 0.92–1.50), leukocytes SMD 1.07 (95% CI 0.25–1.88), interleukin (IL)-6 SMD 0.90 (95% CI 0.48–1.31), IL-8 SMD 2.34 (95% CI 0.69–4.00) and fibrinogen SMD 0.87 (95% CI 0.44–1.31). They did not find a significant relationship between COPD and tumour necrosis factor-α levels.

Xiong et al. [59] identified living at high altitudes (>1500 m) as a possible risk factor for COPD, but it was noted it was not an independent risk factor (mOR 1.18, 95% CI 0.85–1.62). Bellou et al. [79] identified traffic intensity as a possible risk factor and found an mOR of 1.30 (95% CI 0.92–1.82) per 5000 vehicles per day increase on the nearest road and an mOR of 1.26 (95% CI 0.95–1.70) for traffic load on major roads within 100 m per 500 000 vehicles per day increase. However, results were not significant. Adeloye et al. [85] identified living in both rural (mOR 1.40, 95% CI 1.30–1.60) and urban (mOR 1.20, 95% CI 1.00–1.50) areas as a risk factor; however, only the results for living in rural areas were significant.

Yang et al. [57] reported males to be at an increased risk for COPD (mOR 1.47, 95% CI 1.10–1.96), which is in accordance with results from Adeloye et al. [85] (mOR 2.10, 95% CI 1.90–2.30) and Chen et al. [72] (mOR 1.70, 95% CI 1.31–2.22)). They also reported poor housing ventilation, e.g. poor kitchen ventilation (mOR 3.99, 95% CI 1.24–12.82), to increase COPD risk [57]. Yang et al. [57] also found recurrent respiratory infections to increase the risk of COPD (mOR 15.02, 95% CI 4.54–49.68). Bellou et al. [79] identified a history of rheumatoid arthritis (mOR 1.99, 95% CI 1.61–2.45) or psoriasis (mOR 1.45, 95% CI 1.21–1.73) as risk factors for COPD. Four studies identified previous tuberculosis as a risk factor for COPD [61, 85, 93, 94], with mORs of 2.80 (95% CI 1.90–4.00) [85] and 5.98 (95% CI 4.18–8.56) [61].

Lastly, four reviews identified an increased risk of COPD when one of the parents has the condition as well [57, 65, 72, 85], with found mORs ranging from 1.57 (95% CI 1.29–1.93) [65] to 2.07 (95% CI 1.47–2.92) [57], respectively.

Discussion

To the best of our knowledge, this is the first umbrella review that provides an overview and comparison of nongenetic risk factors for COPD and asthma. We identified 43 risk factors for AOA and 45 for COPD. Risk factors were grouped into different categories.

AOA

Two reviews reported wood dust workers to be at an increased risk for asthma [25, 34], which was also one of the workplace irritants included by Baur et al. [44]. This indicates the importance of occupational factors in asthma development, which is supported by the asthma-specific job exposure matrix developed by Kennedy et al. [95]. Additionally, the lowest JBI score was six out of 10, indicating no major issues. Second, a strong association was found between a higher BMI and increased asthma risk [31, 40, 42]. The association was found for both overweight and obese participants, compared to participants with a healthy BMI. Female sex was also associated with late-onset asthma [36] in a review specifically examining AOA. They stated the underlying mechanism was unclear, but that it could be related to lifetime changes in female sex hormones and gender-specific differences in allergic sensitivities [36]. However, male sex was also identified as a risk factor in one review [31]. Lastly, several chemical exposures were associated with asthma, such as formaldehyde [21], VOCs [27], pesticides [46] and phthalates [47]. Three reviews [31, 36, 42] focused on smoking as a risk factor, of which two specified age of onset [36, 42]. Two showed an association with AOA [31, 36]. The third, not showing an association with an increased risk, only included two papers on smoking in total with contradicting results. One found a protective effect and one showed an increased risk [42]. We did not differentiate between allergic and nonallergic asthma as this was not clearly stated in each review, but since we are focusing on adult asthma, most are likely nonallergic cases.

COPD

12 reviews [54, 55, 57, 61, 70, 72, 79, 85–87, 89, 90] stated active smoking, as compared to nonsmokers, to be the main risk factor for COPD. 15 reviews [54, 57, 61, 69, 70, 72, 76, 77, 79, 81, 83, 85, 86, 93, 94] identified indoor biomass burning as a risk factor for COPD. Even though most of those studies were performed in lower income countries, it highlights the importance of particulate matter exposure, and the need for proper ventilation and the use of less damaging fuels indoors (e.g. natural gas, electric instead of solid fuels). Four reviews [57, 60, 72, 82] found ambient PM2.5 and NO2 concentrations to increase COPD risk. According to the World Health Organization (WHO), 99% of the global population lives in places where air pollution levels exceed the WHO requirements [96]. This highlights the need for concrete policies to reduce emissions. Several studies identified early life exposures [50, 52, 57, 68, 70, 72, 80, 85, 92, 93, 94], such as childhood asthma and respiratory problems, as risk factors for COPD. This shows the importance of prioritising children's respiratory health, as the consequences might linger into adulthood.

Three reviews reported a western, unhealthy diet to increase COPD risk [51, 63, 73] and five studies identified low BMI as a risk factor [57, 74, 76]. A proposed biological pathway has been oxidative stress, which is associated with COPD development, and certain foods could have a protective role [97]. This shows how efforts of prevention could take advantage of this protective effect by including lifestyle measures, beyond smoking cessation, and include nutritional counselling. Eight reviews [56–58, 66, 71, 79, 84, 93] identified occupational dust as a risk factor, indicating efforts should be made to reduce dust exposure in the workplace and/or provide workers with protective equipment to mitigate the risk. Lastly, four reviews identified parental COPD as a risk factor independent of having specific genetic variations [57, 65, 72, 85], possibly making it easier to identify people at risk early on.

Differences and similarities

A second aim of this review was to identify both differences and similarities between risk factors for COPD and asthma. One of the main differences is BMI, with a high BMI being a risk factor for asthma, as opposed to a low BMI being a risk factor for COPD, and a high BMI being a protective factor. Second, both male and female sex were found to be risk factors for AOA, while males had a higher risk of COPD. However, Yang et al. [57] mention that currently COPD prevalence in males and females is close to equal, due to changes in smoking behaviour. Furthermore, even though most found risk factors differed, they were not contradicting.

We also found several similarities. First, for both diseases a low birth weight and pre-term delivery were implied as risk factors, even though pre-term delivery was not statistically significant for either. Second, occupational dust exposure was found in multiple reviews for both conditions, indicating an area for prevention. Third, active and passive smoking are important risk factors for both COPD and AOA. Even though the number of included reviews specifically focusing on smoking is limited, most studies adjusted for smoking. Fourth, ambient air pollution, in the form of NO2 and particulate matter, was found to be a risk factor for both COPD and AOA. Finally, both pesticide exposure and exposure to workplace irritants such as chloride, were identified as risk factors for both AOA and COPD.

Strengths and limitations

There were several strengths. First, we conducted a comprehensive search on two highly prevalent diseases and provided an overview of nongenetic risk factors. This could help further develop prevention strategies and aid in the correct classification of both. Second, multiple authors did a partial screening and extraction of data, to limit errors in inclusion and data extraction. Last, because of the design, we were able to include most nongenetic risk factors for both asthma and COPD, which could have been unfeasible otherwise.

The review also has several limitations, which need to be considered. First, only seven out of the 30 studies that examined risk factors for asthma specified AOA, as opposed to asthma in adults. Four more only imply adult onset, as they investigate asthma development since starting work in certain occupational groups, but it is not explicitly specified that this is the case. As we were specifically interested in AOA and not asthma developed early in life, this might have impacted our results. This could be because risk factors for childhood asthma, lingering on into adulthood, are not the same as risk factors for developing asthma at a later age. Additionally, only a few studies confirmed asthma diagnosis by means of specific symptoms in combination with airway reversibility, the other studies did not specify the diagnosis which may result in the inclusion of patients with airway symptoms due to other diseases. Second, asthma studies including only adults were scarce. For most studies, the main focus was on asthma in children, leading to small sample sizes when excluding the population younger than 18 years of age. This lack of studies makes it difficult to draw firm conclusions. Third, for both asthma and COPD, not every review included a meta-analysis and/or provided a quantitative outcome measure or pooled estimates. This made comparing the results more difficult and could have led to some findings being over- or under-represented. However, as we did a risk of bias assessment, with JBI scores ranging between five and 11, this risk might be limited, as none indicated a high risk of bias. Fourth, we included every review regardless of quality and did not distinguish between the different JBI scores when interpreting results. Last, since we focused on incidence, we might have missed risk factors that become more apparent when taking mortality and exacerbations into account, such as ozone.

Implications

As our review provides an overview of risk factors of asthma and COPD, this provides possible targets for early identification and prevention. Since the costs of chronic diseases, both for healthcare and for individual health are high, this might result in significant financial savings and reduce the loss of quality of life [98]. Further, the Global Burden of Disease Study currently calculates risk based on six risk factors for COPD (smoking, second-hand smoke, household air pollution, ambient particulate matter, ozone and occupational particulates) and two for asthma (smoking and occupational asthmagens, e.g. occupational wood dust and cleaning materials) [4]. As this review identified many more risk factors, the burden of disease might currently be underestimated. Additionally, our review has highlighted the differences in risk factors for COPD and AOA, meaning interventions need to be targeted to the specific population at risk.

Our review has also highlighted areas in which more research is needed. Few reviews focus on asthma in adults and even fewer focus on AOA. As research has shown AOA is less atopic and has a worse prognosis than childhood asthma [9], more research into this specific population is needed.

Conclusions

In this umbrella review, we provided an overview of nongenetic risk factors for COPD and AOA. Importantly, both diseases share several known lung-damaging and nongenetic factors such as smoking and occupational exposures. There are also some notable differences, such as BMI and air pollution. More research specifically on AOA should be performed to better understand these risk factors. Overall, the results of this review could help in differentiating between these diseases when diagnosing, as well as more targeted and earlier identification of cases, by identifying people at risk.

Supplementary material

Supplementary Material

Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

Supplementary material ERR-0009-2023.SUPPLEMENT

Footnotes

  • Provenance: Submitted article, peer reviewed.

  • Conflict of interest: A.H. Maitland-Van der Zee is the PI of P4O2 (Precision Medicine for more Oxygen) public–private partnership sponsored by Health Holland involving many private partners who contribute in cash and/or in kind. Partners in the Precision Medicine for more Oxygen (P4O2) consortium are the Amsterdam UMC, Leiden University Medical Center, Maastricht UMC+, Maastricht University, UMC Groningen, UMC Utrecht, Utrecht University, TNO, Aparito, Boehringer Ingelheim, Breathomix, Clear, Danone Nutricia Research, Fluidda, MonitAir, Ncardia, Ortec Logiqcare, Philips, Proefdiervrij, Quantib-U, RespiQ, Roche, Smartfish, SODAQ, Thirona, TopMD, Lung Alliance Netherlands (LAN) and the Lung Foundation Netherlands (Longfonds). The consortium is additionally funded by the PPP Allowance made available by Health Holland, Top Sector Life Sciences & Health (LSHM20104; LSHM20068), to stimulate public-private partnerships and by Novartis. A.H. Maitland-Van der Zee has received grants from Boehringer Ingelheim, Vertex Innovation Award, Dutch Lung Foundation, Stichting Asthma Bestrijding, and Innovative Medicine Initiative (IMI). A.H. Maitland-Van der Zee has received consulting fees from AstraZeneca and Boehringer Ingelheim. A.H. Maitland-Van der Zee has received GSK honarium for a lecture. A.H. Maitland-Van der Zee is the chair of DSMB SOS BPD study and advisory board member of the CHAMP study. A.H. Maitland-Van der Zee is the president of the federation of innovative drug research in the Netherlands (FIGON) and president of the European Association of systems medicine (EASYM). The remaining authors have no conflicts to declare.

  • Support statement: Partners in the Precision Medicine for more Oxygen (P4O2) consortium are the Amsterdam UMC, Leiden University Medical Center, Maastricht UMC+, Maastricht University, UMC Groningen, UMC Utrecht, Utrecht University, TNO, Aparito, Boehringer Ingelheim, Breathomix, Clear, Danone Nutricia Research, Fluidda, MonitAir, Ncardia, Ortec Logiqcare, Philips, Proefdiervrij, Quantib-U, RespiQ, Roche, Smartfish, SODAQ, Thirona, TopMD, Lung Alliance Netherlands (LAN) and the Lung Foundation Netherlands (Longfonds). The consortium is additionally funded by the PPP Allowance made available by Health Holland, Top Sector Life Sciences & Health (LSHM20104; LSHM20068), to stimulate public-private partnerships and by Novartis. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received January 9, 2023.
  • Accepted February 27, 2023.
  • Copyright ©The authors 2023
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

References

  1. ↵
    1. Hajat C,
    2. Stein E
    . The global burden of multiple chronic conditions: a narrative review. Prev Med Rep 2018; 12: 284–293. doi:10.1016/j.pmedr.2018.10.008
    OpenUrlPubMed
  2. ↵
    1. Rycroft CE,
    2. Heyes A,
    3. Lanza L, et al.
    Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 2012; 7: 457–494. doi:10.2147/COPD.S32330
    OpenUrlCrossRefPubMed
  3. ↵
    1. World Health Organization
    . Chronic obstructive pulmonary disease (COPD). www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) Date last updated: 16 March 2023. Date last accessed: 28 September 2022.
  4. ↵
    1. GBD 2015 Chronic Respiratory Disease Collaborators
    . Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017; 5: 691–706. doi:10.1016/S2213-2600(17)30293-X
    OpenUrlPubMed
  5. ↵
    1. Sarkar M,
    2. Srinivasa Madabhavi I, et al.
    Tuberculosis associated chronic obstructive pulmonary disease. Clin Respir J 2017; 11: 285–295. doi:10.1111/crj.12621
    OpenUrl
  6. ↵
    1. Lee CH,
    2. Lee MC,
    3. Shu CC, et al.
    Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis 2013; 13: 194. doi:10.1186/1471-2334-13-194
    OpenUrlCrossRefPubMed
  7. ↵
    1. Schneider C,
    2. Jick SS,
    3. Bothner U, et al.
    COPD and the risk of depression. Chest 2010; 137: 341–347. doi:10.1378/chest.09-0614
    OpenUrlCrossRefPubMed
  8. ↵
    1. Masoli M,
    2. Fabian D,
    3. Holt S, et al.
    The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469–478. doi:10.1111/j.1398-9995.2004.00526.x
    OpenUrlCrossRefPubMed
  9. ↵
    1. de Nijs SB,
    2. Venekamp LN,
    3. Bel EH
    . Adult-onset asthma: is it really different? Eur Respir Rev 2013; 22: 44–52. doi:10.1183/09059180.00007112
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. de Marco R,
    2. Cappa V,
    3. Accordini S, et al.
    Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012; 39: 883–892. doi:10.1183/09031936.00061611
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Postma DS,
    2. Rabe KF
    . The asthma-COPD overlap syndrome. N Engl J Med 2015; 373: 1241–1249. doi:10.1056/NEJMra1411863
    OpenUrlCrossRefPubMed
  12. ↵
    1. Marcon A,
    2. Locatelli F,
    3. Dharmage SC, et al.
    The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories. Eur Respir J 2021; 58: 2004656. doi:10.1183/13993003.04656-2020
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Papaiwannou A,
    2. Zarogoulidis P,
    3. Porpodis K, et al.
    Asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis 2014; 6: Suppl. 1, S146–SS51. doi:10.3978/j.issn.2072-1439.2014.03.04
    OpenUrlCrossRefPubMed
  14. ↵
    1. Menezes AMB,
    2. Montes de Oca M,
    3. Pérez-Padilla R, et al.
    Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD–asthma. Chest 2014; 145: 297–304. doi:10.1378/chest.13-0622
    OpenUrlCrossRefPubMed
  15. ↵
    1. Miravitlles M,
    2. Soriano JB,
    3. Ancochea J, et al.
    Characterisation of the overlap COPD–asthma phenotype. Focus on physical activity and health status. Respir Med 2013; 107: 1053–1060. doi:10.1016/j.rmed.2013.03.007
    OpenUrlCrossRefPubMed
  16. ↵
    1. Martinez FD
    . Early-life origins of chronic obstructive pulmonary disease. N Engl J Med 2016; 375: 871–878. doi:10.1056/NEJMra1603287
    OpenUrlCrossRefPubMed
  17. ↵
    1. To T,
    2. Zhu J,
    3. Larsen K, et al.
    Progression from asthma to chronic obstructive pulmonary disease. Is air pollution a risk factor? Am J Respir Crit Care Med 2016; 194: 429–438. doi:10.1164/rccm.201510-1932OC
    OpenUrlCrossRefPubMed
  18. ↵
    1. Ioannidis JP
    . Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 2009; 181: 488–493. doi:10.1503/cmaj.081086
    OpenUrlFREE Full Text
  19. ↵
    1. Aromataris E,
    2. Fernandez R,
    3. Godfrey CM, et al.
    Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc 2015; 13: 132–140. doi:10.1097/XEB.0000000000000055
    OpenUrlCrossRefPubMed
  20. ↵
    1. Romero Starke K,
    2. Friedrich S,
    3. Schubert M, et al.
    Are healthcare workers at an increased risk for obstructive respiratory diseases due to cleaning and disinfection agents? A systematic review and meta-analysis. Int J Environ Res Public Health 2021; 18: 5159. doi:10.3390/ijerph18105159
    OpenUrl
  21. ↵
    1. Yu L,
    2. Wang B,
    3. Cheng M, et al.
    Association between indoor formaldehyde exposure and asthma: a systematic review and meta-analysis of observational studies. Indoor Air 2020; 30: 682–690. doi:10.1111/ina.12657
    OpenUrl
  22. ↵
    1. Wang X,
    2. Zhou N,
    3. Zhi Y
    . Association between exposure to greenness and atopic march in children and adults–a systematic review and meta-analysis. Front Public Health 2022; 10: 1097486. doi:10.3389/fpubh.2022.1097486
    OpenUrl
  23. ↵
    1. Chen M,
    2. Sun Y,
    3. Wu Y
    . Lower circulating zinc and selenium levels are associated with an increased risk of asthma: evidence from a meta-analysis. Public Health Nutr 2020; 23: 1555–1562. doi:10.1017/S1368980019003021
    OpenUrl
  24. ↵
    1. Etminan M,
    2. Sadatsafavi M,
    3. Jafari S, et al.
    Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest 2009; 136: 1316–1323. doi:10.1378/chest.09-0865
    OpenUrlCrossRefPubMed
  25. ↵
    1. Zhang Y,
    2. Ye B,
    3. Zheng H, et al.
    Association between organic dust exposure and adult-asthma: a systematic review and meta-analysis of case-control studies. Allergy Asthma Immunol Res 2019; 11: 818–829. doi:10.4168/aair.2019.11.6.818
    OpenUrl
  26. ↵
    1. Shen SY,
    2. Xiao WQ,
    3. Lu JH, et al.
    Early life vitamin D status and asthma and wheeze: a systematic review and meta-analysis. BMC Pulm Med 2018; 18: 120. doi:10.1186/s12890-018-0679-4
    OpenUrl
  27. ↵
    1. Nurmatov U,
    2. Tagieva N,
    3. Semple S, et al.
    Volatile organic compounds and risk of asthma and allergy: a systematic review and meta-analysis of observational and interventional studies. Primary Care Respir J 2013; 22: PS9–PS15. doi:10.4104/pcrj.2013.00010
    OpenUrl
  28. ↵
    1. Sharpe RA,
    2. Bearman N,
    3. Thornton CR, et al.
    Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. J Allergy Clin Immunol 2015; 135: 110–122. doi:10.1016/j.jaci.2014.07.002
    OpenUrlCrossRefPubMed
  29. ↵
    1. Mu M,
    2. Ye S,
    3. Bai MJ, et al.
    Birth weight and subsequent risk of asthma: a systematic review and meta-analysis. Heart Lung Circ 2014; 23: 511–519. doi:10.1016/j.hlc.2013.11.018
    OpenUrlCrossRefPubMed
  30. ↵
    1. Macan J,
    2. Babić Ž,
    3. Hallmann S, et al.
    Respiratory toxicity of persulphate salts and their adverse effects on airways in hairdressers: a systematic review. Int Arch Occup Environ Health 2022; 95: 1679–1702. doi:10.1007/s00420-022-01852-w
    OpenUrl
  31. ↵
    1. Sio YY,
    2. Chew FT
    . Risk factors of asthma in the Asian population: a systematic review and meta-analysis. J Physiol Anthropol 2021; 40: 22. doi:10.1186/s40101-021-00273-x
    OpenUrl
  32. ↵
    1. Rodriguez A,
    2. Brickley E,
    3. Rodrigues L, et al.
    Urbanisation and asthma in low-income and middle-income countries: a systematic review of the urban-rural differences in asthma prevalence. Thorax 2019; 11: 1020–1030. doi:10.1136/thoraxjnl-2018-211793
    OpenUrl
  33. ↵
    1. Cong X,
    2. Xu X,
    3. Zhang Y, et al.
    Temperature drop and the risk of asthma: a systematic review and meta-analysis. Environ Sci Pollut Res Int 2017; 24: 22535–22546. doi:10.1007/s11356-017-9914-4
    OpenUrl
  34. ↵
    1. Wiggans RE,
    2. Evans G,
    3. Fishwick D, et al.
    Asthma in furniture and wood processing workers: a systematic review. Occup Med 2016; 66: 193–201. doi:10.1093/occmed/kqv149
    OpenUrlCrossRefPubMed
  35. ↵
    1. Uphoff E,
    2. Cabieses B,
    3. Pinart M, et al.
    A systematic review of socioeconomic position in relation to asthma and allergic diseases. Eur Respir J 2015; 46: 364–374. doi:10.1183/09031936.00114514
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Tan DJ,
    2. Walters EH,
    3. Perret JL, et al.
    Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature. Expert Rev Respir Med 2015; 9: 109–123. doi:10.1586/17476348.2015.1000311
    OpenUrlCrossRefPubMed
  37. ↵
    1. Lieberoth S,
    2. Gade EJ,
    3. Brok J, et al.
    Age at menarche and risk of asthma: systematic review and meta-analysis. J Asthma 2014; 51: 559–565. doi:10.3109/02770903.2014.903966
    OpenUrlCrossRefPubMed
  38. ↵
    1. Kakutani S,
    2. Egawa K,
    3. Saito K, et al.
    Arachidonic acid intake and asthma risk in children and adults: a systematic review of observational studies. J Nutr Sci 2014; 3: e12. doi:10.1017/jns.2014.9
    OpenUrl
  39. ↵
    1. Takkouche B,
    2. González-Barcala FJ,
    3. Etminan M, et al.
    Exposure to furry pets and the risk of asthma and allergic rhinitis: a meta-analysis. Allergy 2008; 63: 857–864. doi:10.1111/j.1398-9995.2008.01732.x
    OpenUrlCrossRefPubMed
  40. ↵
    1. Beuther DA,
    2. Sutherland ER
    . Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175: 661–666. doi:10.1164/rccm.200611-1717OC
    OpenUrlCrossRefPubMed
  41. ↵
    1. Jaakkola JJ,
    2. Ahmed P,
    3. Ieromnimon A, et al.
    Preterm delivery and asthma: a systematic review and meta-analysis. J Allergy Clin Immunol 2006; 118: 823–830. doi:10.1016/j.jaci.2006.06.043
    OpenUrlCrossRefPubMed
  42. ↵
    1. Mikkelsen H,
    2. Landt EM,
    3. Benn M, et al.
    Causal risk factors for asthma in Mendelian randomization studies: a systematic review and meta-analysis. Clin Transl Allergy 2022; 12: e12207. doi:10.1002/clt2.12207
    OpenUrl
  43. ↵
    1. Canova C,
    2. Jarvis D,
    3. Walker S, et al.
    Systematic review of the effects of domestic paints on asthma related symptoms in people with or without asthma. J Asthma 2013; 50: 1020–1030. doi:10.3109/02770903.2013.834931
    OpenUrl
  44. ↵
    1. Baur X,
    2. Bakehe P,
    3. Vellguth H
    . Bronchial asthma and COPD due to irritants in the workplace – an evidence-based approach. J Occup Med Toxicol 2012; 7: 19. doi:10.1186/1745-6673-7-19
    OpenUrlCrossRefPubMed
  45. ↵
    1. Flaherman V,
    2. Rutherford GW
    . A meta-analysis of the effect of high weight on asthma. Arch Dis Child 2006; 91: 334–339. doi:10.1136/adc.2005.080390
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Doust E,
    2. Ayres JG,
    3. Devereux G, et al.
    Is pesticide exposure a cause of obstructive airways disease? Eur Respir Rev 2014; 23: 180–192. doi:10.1183/09059180.00005113
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Jaakkola JJ,
    2. Knight TL
    . The role of exposure to phthalates from polyvinyl chloride products in the development of asthma and allergies: a systematic review and meta-analysis. Environ Health Perspect 2008; 116: 845–853. doi:10.1289/ehp.10846
    OpenUrlPubMed
  48. ↵
    1. Folletti I,
    2. Zock JP,
    3. Moscato G, et al.
    Asthma and rhinitis in cleaning workers: a systematic review of epidemiological studies. J Asthma 2014; 51: 18–28. doi:10.3109/02770903.2013.833217
    OpenUrlCrossRefPubMed
  49. ↵
    1. Vincent MJ,
    2. Parker A,
    3. Maier A
    . Cleaning and asthma: a systematic review and approach for effective safety assessment. Regul Toxicol Pharmacol 2017; 90: 231–243. doi:10.1016/j.yrtph.2017.09.013
    OpenUrl
  50. ↵
    1. Duan P,
    2. Wang Y,
    3. Lin R, et al.
    Impact of early life exposures on COPD in adulthood: a systematic review and meta-analysis. Respirology 2021; 26: 1131–1151. doi:10.1111/resp.14144
    OpenUrl
  51. ↵
    1. Parvizian MK,
    2. Dhaliwal M,
    3. Li J, et al.
    Relationship between dietary patterns and COPD: a systematic review and meta-analysis. ERJ Open Res 2020; 6: 00168-2019. doi:10.1183/23120541.00168-2019
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Asamoah-Boaheng M,
    2. Acheampong L,
    3. Tenkorang EY, et al.
    Association between early history of asthma and COPD diagnosis in later life: a systematic review and meta-analysis. Int J Epidemiol 2018; 47: 1865–1876. doi:10.1093/ije/dyy207
    OpenUrl
  53. ↵
    1. Su B,
    2. Liu T,
    3. Fan H, et al.
    Inflammatory markers and the risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One 2016; 11: e0150586. doi:10.1371/journal.pone.0150586
    OpenUrl
  54. ↵
    1. Awokola BI,
    2. Amusa GA,
    3. Jewell CP, et al.
    Chronic obstructive pulmonary disease in sub-Saharan Africa. Int J Tuberc Lung Dis 2022; 26: 232–242. doi:10.5588/ijtld.21.0394
    OpenUrlCrossRef
  55. ↵
    1. Kamal R,
    2. Srivastava AK,
    3. Kesavachandran CN
    . Meta-analysis approach to study the prevalence of chronic obstructive pulmonary disease among current, former and non-smokers. Toxicol Rep 2015; 2: 1064–1074. doi:10.1016/j.toxrep.2015.07.013
    OpenUrl
  56. ↵
    1. Sadhra S,
    2. Kurmi OP,
    3. Sadhra SS, et al.
    Occupational COPD and job exposure matrices: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2017; 12: 725–734. doi:10.2147/COPD.S125980
    OpenUrl
  57. ↵
    1. Yang Y,
    2. Mao J,
    3. Ye Z, et al.
    Risk factors of chronic obstructive pulmonary disease among adults in Chinese mainland: a systematic review and meta-analysis. Respir Med 2017; 131: 158–165. doi:10.1016/j.rmed.2017.08.018
    OpenUrl
  58. ↵
    1. Peng C,
    2. Yan Y,
    3. Li Z, et al.
    Chronic obstructive pulmonary disease caused by inhalation of dust: a meta-analysis. Medicine 2020; 99: e21908. doi:10.1097/MD.0000000000021908
    OpenUrl
  59. ↵
    1. Xiong H,
    2. Huang Q,
    3. He C, et al.
    Prevalence of chronic obstructive pulmonary disease at high altitude: a systematic review and meta-analysis. PeerJ 2020; 8: e8586. doi:10.7717/peerj.8586
    OpenUrl
  60. ↵
    1. Park J,
    2. Kim HJ,
    3. Lee CH, et al.
    Impact of long-term exposure to ambient air pollution on the incidence of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Environ Res 2021; 194: 110703. doi:10.1016/j.envres.2020.110703
    OpenUrl
  61. ↵
    1. Njoku CM,
    2. Hurst JR,
    3. Kinsman L, et al.
    COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes-a systematic review and meta-analysis. Thorax 2023; in press [https://doi.org/10.1136/thorax-2022-218675]
  62. ↵
    1. Gershon AS,
    2. Dolmage TE,
    3. Stephenson A, et al.
    Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD 2012; 9: 216–226. doi:10.3109/15412555.2011.648030
    OpenUrlCrossRefPubMed
  63. ↵
    1. Zheng PF,
    2. Shu L,
    3. Si CJ, et al.
    Dietary patterns and chronic obstructive pulmonary disease: a meta-analysis. COPD 2016; 13: 515–522. doi:10.3109/15412555.2015.1098606
    OpenUrl
  64. ↵
    1. Ryu JY,
    2. Sunwoo YE,
    3. Lee SY, et al.
    Chronic obstructive pulmonary disease (COPD) and vapors, gases, dusts, or fumes (VGDF): a meta-analysis. COPD 2015; 12: 374–380. doi:10.3109/15412555.2014.949000
    OpenUrlCrossRefPubMed
  65. ↵
    1. Li LS,
    2. Paquet C,
    3. Johnston K, et al.
    ‘What are my chances of developing COPD if one of my parents has the disease?’ A systematic review and meta-analysis of prevalence of co-occurrence of COPD diagnosis in parents and offspring. Int J Chron Obstruct Pulmon Dis 2017; 12: 403–415. doi:10.2147/COPD.S123933
    OpenUrl
  66. ↵
    1. Borup H,
    2. Kirkeskov L,
    3. Hanskov DJA, et al.
    Systematic review: chronic obstructive pulmonary disease and construction workers. Occup Med 2017; 67: 199–204. doi:10.1093/occmed/kqx007
    OpenUrlPubMed
  67. ↵
    1. Guillien A,
    2. Soumagne T,
    3. Dalphin JC, et al.
    COPD, airflow limitation and chronic bronchitis in farmers: a systematic review and meta-analysis. Occup Environ Med 2019; 76: 58–68. doi:10.1136/oemed-2018-105310
    OpenUrlAbstract/FREE Full Text
  68. ↵
    1. Ma H,
    2. Li Y,
    3. Tang L, et al.
    Impact of childhood wheezing on lung function in adulthood: a meta-analysis. PLoS One 2018; 13: e0192390. doi:10.1371/journal.pone.0192390
    OpenUrl
  69. ↵
    1. Kamal R,
    2. Srivastava AK,
    3. Kesavachandran CN, et al.
    Chronic obstructive pulmonary disease (COPD) in women due to indoor biomass burning: a meta analysis. Int J Environ Health Res 2022; 32: 1403–1417. doi:10.1080/09603123.2021.1887460
    OpenUrl
  70. ↵
    1. Sutradhar I,
    2. Das Gupta R,
    3. Hasan M, et al.
    Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: a systematic review. Cureus 2019; 11: e3970. doi:10.7759/cureus.3970
    OpenUrl
  71. ↵
    1. Vinnikov D,
    2. Rybina T,
    3. Strizhakov L, et al.
    Occupational burden of chronic obstructive pulmonary disease in the commonwealth of independent states: systematic review and meta-analysis. Front Med 2020; 7: 614827. doi:10.3389/fmed.2020.614827
    OpenUrl
  72. ↵
    1. Chen H,
    2. Liu X,
    3. Gao X, et al.
    Epidemiological evidence relating risk factors to chronic obstructive pulmonary disease in China: a systematic review and meta-analysis. PLoS One 2021; 16: e0261692. doi:10.1371/journal.pone.0261692
    OpenUrl
  73. ↵
    1. van Iersel LEJ,
    2. Beijers R,
    3. Gosker HR, et al.
    Nutrition as a modifiable factor in the onset and progression of pulmonary function impairment in COPD: a systematic review. Nutr Rev 2021; 80: 1434–1444. doi:10.1093/nutrit/nuab077
    OpenUrl
  74. ↵
    1. Zhang X,
    2. Chen H,
    3. Gu K, et al.
    Association of body mass index with risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. COPD 2021; 18: 101–113. doi:10.1080/15412555.2021.1884213
    OpenUrl
  75. ↵
    1. Gan WQ,
    2. Man SF,
    3. Postma DS, et al.
    Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 2006; 1: 52. doi:10.1186/1465-9921-7-52
    OpenUrl
  76. ↵
    1. Finney LJ,
    2. Feary JR,
    3. Leonardi-Bee J, et al.
    Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuberc Lung Dis 2013; 17: 583–589. doi:10.5588/ijtld.12.0619
    OpenUrlPubMed
  77. ↵
    1. Zhu B,
    2. Wang Y,
    3. Ming J, et al.
    Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis 2018; 13: 1353–13. doi:10.2147/COPD.S161555
    OpenUrlCrossRefPubMed
  78. ↵
    1. Salari-Moghaddam A,
    2. Milajerdi A,
    3. Larijani B, et al.
    Processed red meat intake and risk of COPD: a systematic review and dose-response meta-analysis of prospective cohort studies. Clin Nutr 2019; 38: 1109–1116. doi:10.1016/j.clnu.2018.05.020
    OpenUrl
  79. ↵
    1. Bellou V,
    2. Belbasis L,
    3. Konstantinidis AK, et al.
    Elucidating the risk factors for chronic obstructive pulmonary disease: an umbrella review of meta-analyses. Int J Tuberc Lung Dis 2019; 23: 58–66. doi:10.5588/ijtld.18.0228
    OpenUrlCrossRefPubMed
  80. ↵
    1. Ali KM
    . Childhood asthma as a risk factor for adult chronic obstructive pulmonary disease: a systematic review and meta-analysis. Expert Rev Respir Med 2022; 16: 461–467. doi:10.1080/17476348.2021.1864328
    OpenUrl
  81. ↵
    1. Pathak U,
    2. Gupta NC,
    3. Suri JC
    . Risk of COPD due to indoor air pollution from biomass cooking fuel: a systematic review and meta-analysis. Int J Environ Health Res 2020; 30: 75–88. doi:10.1080/09603123.2019.1575951
    OpenUrlPubMed
  82. ↵
    1. Zhang Z,
    2. Wang J,
    3. Lu W
    . Exposure to nitrogen dioxide and chronic obstructive pulmonary disease (COPD) in adults: a systematic review and meta-analysis. Environ Sci Pollut Res Int 2018; 25: 15133–15145. doi:10.1007/s11356-018-1629-7
    OpenUrlPubMed
  83. ↵
    1. Kurmi OP,
    2. Semple S,
    3. Simkhada P, et al.
    COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax 2010; 65: 221–228. doi:10.1136/thx.2009.124644
    OpenUrlAbstract/FREE Full Text
  84. ↵
    1. Brüske I,
    2. Thiering E,
    3. Heinrich J, et al.
    Biopersistent granular dust and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One 2013; 8: e80977. doi:10.1371/journal.pone.0080977
    OpenUrlCrossRefPubMed
  85. ↵
    1. Adeloye D,
    2. Song P,
    3. Zhu Y, et al.
    Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med 2022; 10: 447–458. doi:10.1016/S2213-2600(21)00511-7
    OpenUrl
  86. ↵
    1. Budhathoki P,
    2. Shrestha DB,
    3. Sedhai YR, et al.
    Prevalence and risk factors of COPD in Nepal: a systematic review and meta-analysis. J Nepal Health Res Counc 2022; 19: 652–660. doi:10.33314/jnhrc.v19i04.3543
    OpenUrl
  87. ↵
    1. Lee PN,
    2. Forey BA,
    3. Thornton AJ, et al.
    The relationship of cigarette smoking in Japan to lung cancer, COPD, ischemic heart disease and stroke: a systematic review. F1000Res 2018; 7: 204. doi:10.12688/f1000research.14002.1
    OpenUrl
  88. ↵
    1. Fontana L,
    2. Lee SJ,
    3. Capitanelli I, et al.
    Chronic obstructive pulmonary disease in farmers: a systematic review. J Occup Environ Med 2017; 59: 775–788. doi:10.1097/JOM.0000000000001072
    OpenUrlCrossRefPubMed
  89. ↵
    1. Wang B,
    2. Xiao D,
    3. Wang C
    . Smoking and chronic obstructive pulmonary disease in Chinese population: a meta-analysis. Clin Respir J 2015; 9: 165–175. doi:10.1111/crj.12118
    OpenUrl
  90. ↵
    1. Forey BA,
    2. Thornton AJ,
    3. Lee PN
    . Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011; 11: 36. doi:10.1186/1471-2466-11-36
    OpenUrlCrossRefPubMed
  91. ↵
    1. Chaudhary D,
    2. Sharma N,
    3. Senapati S
    . Serum homocysteine could be used as a predictive marker for chronic obstructive pulmonary disease: a meta-analysis. Front Public Health 2019; 7: 69. doi:10.3389/fpubh.2019.00069
    OpenUrl
  92. ↵
    1. Lee PN,
    2. Forey BA,
    3. Coombs KJ, et al.
    Epidemiological evidence relating environmental smoke to COPD in lifelong non-smokers: a systematic review. F1000Res 2018; 7: 146. doi:10.12688/f1000research.13887.1
    OpenUrl
  93. ↵
    1. Cunalata-Paredes AV,
    2. Gea-Izquierdo E
    . COPD in the major nonsmoking adult: a systematic review and meta-analysis. Arch Environ Occup Health 2021; 76: 319–329. doi:10.1080/19338244.2020.1828243
    OpenUrl
  94. ↵
    1. Pando-Sandoval A,
    2. Ruano-Ravina A,
    3. Candal-Pedreira C, et al.
    Risk factors for chronic obstructive pulmonary disease in never-smokers: a systematic review. Clin Respir J 2022; 16: 261–275. doi:10.1111/crj.13479
    OpenUrl
  95. ↵
    1. Kennedy SM,
    2. Le Moual N,
    3. Choudat D, et al.
    Development of an asthma specific job exposure matrix and its application in the epidemiological study of genetics and environment in asthma (EGEA). Occup Environ Med 2000; 57: 635–641. doi:10.1136/oem.57.9.635
    OpenUrlAbstract/FREE Full Text
  96. ↵
    1. World Health Organization
    . Air pollution data portal. www.who.int/data/gho/data/themes/air-pollution Date last updated: 2023. Date last accessed: 4 November 2022.
  97. ↵
    1. Romieu I
    . Nutrition and lung health. Int J Tuberc Lung Dis 2005; 9: 362–374.
    OpenUrlPubMed
  98. ↵
    1. May SM,
    2. Li JT
    . Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc 2015; 36: 4–10. doi:10.2500/aap.2015.36.3812
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
View this article with LENS
Vol 32 Issue 168 Table of Contents
European Respiratory Review: 32 (168)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Identifying risk factors for COPD and adult-onset asthma: an umbrella review
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Identifying risk factors for COPD and adult-onset asthma: an umbrella review
Judith C.S. Holtjer, Lizan D. Bloemsma, Rosanne J.H.C.G. Beijers, Merel E.B. Cornelissen, Bart Hilvering, Laura Houweling, Roel C.H. Vermeulen, George S. Downward, Anke-Hilse Maitland-Van der Zee
European Respiratory Review Jun 2023, 32 (168) 230009; DOI: 10.1183/16000617.0009-2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Identifying risk factors for COPD and adult-onset asthma: an umbrella review
Judith C.S. Holtjer, Lizan D. Bloemsma, Rosanne J.H.C.G. Beijers, Merel E.B. Cornelissen, Bart Hilvering, Laura Houweling, Roel C.H. Vermeulen, George S. Downward, Anke-Hilse Maitland-Van der Zee
European Respiratory Review Jun 2023, 32 (168) 230009; DOI: 10.1183/16000617.0009-2023
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Background
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Supplementary material
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Efficacy and safety of gefapixant for chronic cough
  • Phenotype overlap in the natural history of asthma
  • Furin as a therapeutic target in CF airways disease
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society